Carles Besses

Hospital Del Mar — Spain

Medicine · Health Sciences

26h-index3.1kcitations101works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Myeloproliferative Neoplasms: Diagnosis and Treatment(49), Acute Myeloid Leukemia Research(25), Lymphoma Diagnosis and Treatment(24), Kruppel-like factors research(23), Chronic Myeloid Leukemia Treatments(18)

Publications101 total

Identification of Two Novel EPOR Gene Variants in Primary Familial Polycythemia: Case Report and Literature Review
Genes·2022· 4 citedOpen Access
Molecular and cytogenetic characterization of myelodysplastic syndromes in cell-free DNA
Blood Advances·2022· 15 citedOpen Access
Clonal Dynamics of <i>JAK2</i>V617F and <i>Non-Driver</i> Mutations in Polycythemia Vera and Essential Thrombocythemia Patients Receiving Hydroxyurea Therapy
Blood·2021· 1 cited
Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes
Blood·2021
Molecular Characterization and Clinical Outcomes of Young Adult Patients (≤45 years old) with Philadelphia-Negative Myeloproliferative Neoplasms
Blood·2020
Molecular Characterization of Ph-Negative Myeloproliferative Neoplasms in Tumor Circulating Nucleic Acids
Blood·2019
Pemphigus‐like hypereosinophilic syndrome with <i><scp>FIP</scp>1L1–<scp>PDGFRA</scp></i> fusion gene: A challenging and uncommon clinical presentation
The Journal of Dermatology·2019· 6 cited
Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and <i>ZFP36L1</i> as a potential tumor suppressor gene that is epigenetically regulated
Haematologica·2019· 34 citedOpen Access
Rapidly Growing and Aggressive Cutaneous Squamous Cell Carcinomas in a Patient Treated with Ruxolitinib
Annals of Dermatology·2019· 8 citedOpen Access
Long-Term Efficacy and Safety (5 Years) in RESPONSE, a Phase 3 Study Comparing Ruxolitinib (rux) with Best Available Therapy (BAT) in Hydroxyurea (HU)-Resistant/Intolerant Patients (pts) with Polycythemia Vera (PV)
Blood·2018· 7 cited
rs2431697, a Polymorphism of Mir-146a, Is a Precozing Marker of Progression to Secondary Myelofibrosis: New Epigenetic Regulation of Jak/Stat3 Signaling
Blood·2018
Non-driver mutations in patients with JAK2V617F-mutated polycythemia vera or essential thrombocythemia with long-term molecular follow-up
Annals of Hematology·2017· 44 cited
Incorporation of a Nurse Case Manager for the Diagnosis and Follow Up of Patients with Multiple Myeloma
Clinical Lymphoma Myeloma & Leukemia·2017
MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis
Cancer Genomics & Proteomics·2017· 33 citedOpen Access
Hematological disorders: a commonly unrecognized cause of acute stroke
Expert Review of Hematology·2016· 84 cited
Characterization of CD34+ hematopoietic progenitor cells in JAK2 V617F and CALR -mutated myeloproliferative neoplasms
Leukemia Research·2016· 12 cited
Frequency and prognostic value of resistance/intolerance to hydroxycarbamide in 890 patients with polycythaemia vera
British Journal of Haematology·2015· 77 citedOpen Access
Antitumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells
Clinical Lymphoma Myeloma & Leukemia·2015· 1 cited
Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells
Leukemia & lymphoma/Leukemia and lymphoma·2015· 14 cited
Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia
Medicina Clínica (English Edition)·2015· 3 cited
page 1 of 6Next →

Frequent Co-authors

Beatríz Bellosillo(23), Alberto Álvarez‐Larrán(19), Lourdes Florensa(16), Françesc Solé(13), Blanca Espinet(13), Anna Angona(11), Juan Carlos Hernández‐Boluda(9), Luz Martínez‐Avilés(8), Sergi Serrano(8), S Woessner(8), Francisco Cervantes(7), Antonio Salar(7), Francisca Ferrer‐Marín(6), Montse Gómez(6), J Sans-Sabrafén(6), Raquel Longarón(6), Arturo Pereira(5), Águeda Ancochea(5), Eva Gimeno(5), Elisabet Lloveras(5)